• Wiley Online Library will be disrupted on 18 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Zuschrift

Binaphthyl-Based Dicationic Peptoids with Therapeutic Potential†

  1. John B. Bremner Prof.1,
  2. Paul A. Keller Assoc. Prof.1,
  3. Stephen G. Pyne Prof.1,
  4. Timothy P. Boyle Dr.1,
  5. Zinka Brkic Dr.1,
  6. Dorothy M. David1,
  7. Adel Garas Dr.1,
  8. Jody Morgan Dr.1,
  9. Mark Robertson Dr.1,
  10. Kittiya Somphol Dr.1,
  11. Michael H. Miller Dr.3,
  12. Adam S. Howe Dr.3,
  13. Paul Ambrose Dr.3,
  14. Sujata Bhavnani Dr.3,
  15. Thomas R. Fritsche Dr.4,
  16. Douglas J. Biedenbach Dr.4,
  17. Ronald N. Jones Dr.4,
  18. Robert W. Buckheit Jr. Dr.5,
  19. Karen M. Watson5,
  20. Dean Baylis2,
  21. Jonathan A. Coates Dr.2,
  22. John Deadman Dr.2,
  23. Dharshini Jeevarajah2,
  24. Andrea McCracken Dr.2,
  25. David I. Rhodes Dr.2

Article first published online: 11 DEC 2009

DOI: 10.1002/ange.200904392

Issue

Angewandte Chemie

Angewandte Chemie

Volume 122, Issue 3, pages 547–550, January 12, 2010

Additional Information

How to Cite

Bremner, John B., Keller, Paul A., Pyne, Stephen G., Boyle, Timothy P., Brkic, Z., David, Dorothy M., Garas, A., Morgan, J., Robertson, M., Somphol, K., Miller, Michael H., Howe, Adam S., Ambrose, P., Bhavnani, S., Fritsche, Thomas R., Biedenbach, Douglas J., Jones, Ronald N., Buckheit, Robert W., Watson, Karen M., Baylis, D., Coates, Jonathan A., Deadman, J., Jeevarajah, D., McCracken, A. and Rhodes, David I. (2010), Binaphthyl-Based Dicationic Peptoids with Therapeutic Potential. Angew. Chem., 122: 547–550. doi: 10.1002/ange.200904392

Author Information

  1. 1

    School of Chemistry, University of Wollongong, Wollongong, NSW 2522 (Australia), Fax: (+61) 2-42214287

  2. 2

    Avexa Ltd, 576 Swan Street, Richmond, Victoria 3121 (Australia)

  3. 3

    Institute for Clinical Pharmacodynamics, Ordway Research Institute, 43 British American Blvd, Latham, NY (USA)

  4. 4

    JMI Laboratories, North Liberty, Iowa (USA).

  5. 5

    ImQuest BioSciences, Inc. Frederick, MD 21704 (USA).

  1. †

    We thank the National Health and Medical Research Council (Development Grants 303415 and 404528), the Uni. of Wollongong, and Avexa Ltd for financial support; R. Nation (Monash University) for assistance with some testing against Gram-negative pathogens; and Washington Biosciences, Inc, Maryland (USA) for the nasal decolonisation and systemic studies.

Publication History

  1. Issue published online: 7 JAN 2010
  2. Article first published online: 11 DEC 2009
  3. Manuscript Revised: 7 SEP 2009
  4. Manuscript Received: 6 AUG 2009

Funded by

  • National Health and Medical Research Council. Grant Numbers: 303415, 404528
  • Uni. of Wollongong

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (409K)

Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.

FilenameFormatSizeDescription
ange_200904392_sm_miscellaneous_information.pdf864Kmiscellaneous_information

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (409K)